Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
The Journal of Rheumatology|December 19, 1998
Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical responseN N Barry, J L McGuire, R F van VollenhovenArthritis and Rheumatism|December 1, 1995
Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trialR F van Vollenhoven, E G Engleman, J L McGuireJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritisS G Sundaramurthy, M P Karsevar, R F van VollenhovenArthritis and Rheumatism|September 1, 1994
An open study of dehydroepiandrosterone in systemic lupus erythematosusR F van Vollenhoven, E G Engleman, J L McGuireAnnals of the Rheumatic Diseases|June 15, 2004
Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical descriptionM C Wick, S Lindblad, L Klareskog, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trialR F van Vollenhoven, S Wax, Y Li, et al.Current Rheumatology Reports|May 14, 2018
Gender Differences in Axial Spondyloarthritis: Women Are Not So LuckyT Rusman, R F van Vollenhoven, I E van der Horst-BruinsmaArthritis and Rheumatism|April 1, 2011
Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trialR F van Vollenhoven, N Kinnman, E Vincent, et al.Annals of the Rheumatic Diseases|May 28, 2009
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)J Augustsson, M Neovius, C Cullinane-Carli, et al.The Journal of Rheumatology|March 7, 1998
Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 monthsR F van Vollenhoven, L M Morabito, E G Engleman, et al.Pageof 8